SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on November 13, 2024. The registrant is incorporated in Delaware and its common stock trades on The NASDAQ Capital Market under the symbol BSGM. The report addresses a specific regulatory event regarding listing compliance rather than a standard financial reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a Current Report focused on corporate governance and listing status, not financial performance.
Material Changes and Events
- Listing Deficiency: On October 24, 2024, the Nasdaq Listing Qualifications staff notified the Company that its common stock failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days.
- Regained Compliance: The Company's closing bid price remained at $1.00 per share or greater for 10 consecutive business days from October 30, 2024, to November 12, 2024.
- Resolution: The Company has regained compliance with Listing Rule 5550(a)(2), and the matter is now closed.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on financial outlook, or new risk factors. The primary risk addressed was the potential delisting due to low stock price, which has been resolved as of the filing date. A press release dated November 13, 2024, is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the current trading price of BSGM to ensure it remains above the $1.00 threshold to avoid future compliance notices.
- Review the press release (Exhibit 99.1) for any additional context on the stock price recovery.
- Confirm the company's status on the Nasdaq Capital Market to ensure no further delisting proceedings are active.